Project measures / variables set:   Schoonjans1   TbMCA_plasma_t30

ID, description, units MPD:112702   TbMCA_plasma_t30   plasma bile acid tauro-β-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min   [ng/mL]  
high-fat diet study
Measures • CD    • HFD
Data set, strains Schoonjans1   BXD w/par   36 strains     sex: m     age: 20wks
Procedure biomarker quantification
Comparisoncontrol group vs. treated group
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Schoonjans1 - plasma bile acid tauro-β-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
group 1 876391.8558 876391.8558 43.0871 < 0.0001
group:strain 35 1060162.5956 30290.3599 1.4892 0.0445
Residuals 252 5125682.4498 20340.0097
strain 35 2764853.6883 78995.8197 3.8838 < 0.0001

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
Schoonjans1 112702 biomarker quantification high-fat diet plasma bile acid tauro-β-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min   [ng/mL]   CD  TbMCA_plasma_t30_CD BXD w/par 36 m 20wks
Schoonjans1 112703 biomarker quantification high-fat diet plasma bile acid tauro-β-muricholic acid amount, glucose kinetic test, at 20 wks of age, after 30 min   [ng/mL]   HFD  TbMCA_plasma_t30_HFD BXD w/par 36 m 20wks